Praluent is.......

Discussion in 'Regeneron' started by anonymous, Jan 6, 2017 at 4:14 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Yeah I did. And i kicked arse over there as well..
     

  2. anonymous

    anonymous Guest


    Being a good amgen rep is like winning the special olympics!
     
  3. anonymous

    anonymous Guest

    You said that right!!
     
  4. anonymous

    anonymous Guest

    Yeah sure you did?
     
  5. anonymous

    anonymous Guest

    Thats right you lazy fuck. I kicked arse like you couldn't believe it.
     
  6. anonymous

    anonymous Guest

    Another blockbuster drug potential cluster F'd by REGN.

    Time to F up Dupi next.

    Sorry patients, you're dealing with paramount incompetence unsurpassed for decades.

    Regeneron excels at failure, that's a positive we can work on.
     
  7. anonymous

    anonymous Guest

    We hired enough Amgen rejects mixed with our home grown hill billies to fuck up any product.
     
  8. anonymous

    anonymous Guest

    Speaking of fuck ups, how you taking it? In the ass or ear?
     
  9. anonymous

    anonymous Guest

    Amgen can't fuck up this bad..out selling Praluent 11% over 2% growth. Time to shoot the dead drug already.

    Remember, Dupi next, called it a year ago.
     
  10. anonymous

    anonymous Guest

    Praluent is taking over $200MM to maintain on an annual basis. Brought in measly $39MM last quarter.

    Let's shoot that looooser product and people who worked on it so the company can focus on reviving Dupi.

    Dupi looks like a fucking Orphan indication now for Len's sake!!!!
     
  11. anonymous

    anonymous Guest

    So what is the latest on Praluent? I was following early on and thought is was a great idea.
     
  12. anonymous

    anonymous Guest

    Same as Sum-Shit-MAB (REGN2222).